CSI Product Changes Sample Clauses
The CSI Product Changes clause defines the process and conditions under which modifications to CSI products may be made during the term of an agreement. Typically, this clause outlines the procedures for proposing, approving, and implementing changes, including notification requirements and any limitations on the scope of permissible changes. Its core practical function is to provide a structured framework for managing product updates or alterations, ensuring both parties are informed and in agreement, thereby reducing the risk of disputes or misunderstandings related to product modifications.
CSI Product Changes. CSI shall inform NK about any material changes of specification or any other material changes to the Products at least 180 days prior to their implementation. If any proposed modification might affect the performance, quality or functioning of critical components of Products or the approvals, permissions, consents or licenses applicable to them, CSI shall not modify the Products unless NK has given its consent to the modification in writing. If NK gives its consent to the proposed modification, the modified Products shall replace the prior version of the Products and the terms and conditions of this Agreement shall continue to apply. If the modified Products are not acceptable to NK, CSI shall, if feasible, continue to deliver to NK unmodified Products. Concerning the Electrodes, if the modification relates to a change in the gel material, CSI shall provide NK with the modification notice and biocompatibility data at least 180 days prior to the proposed date of shipment of the modified Electrodes.
CSI Product Changes. Section 5.5 shall be replaced as follows: CSI shall inform about any material changes of specification or any other material changes to the Products at least 180 days prior to their implementation. If any proposed modification might affect the performance, quality or functioning of the critical component of Products or the approvals, permissions, consents or licenses applicable to them, CSI shall not modify the Products unless NK has given its consent to the modification in writing. If NK gives its consent to the proposed modification, the modified Products shall replace the prior version of the Products and the terms and conditions of this Agreement shall continue to apply. If the modified Products are not acceptable to NK, CSI shall, if feasible, continue to deliver to NK unmodified Products. Concerning the Electrodes, if the modification relates to a change in the gel material, CSI shall provide NK with the modification notice and biocompatibility data at least 180 days prior to the proposed date of shipment of the modified Electrodes.